2 nominees · 6 ballot items.
Elect two directors; advisory say-on-pay for 2025 executive compensation; ratify Semple, Marchal & Cooper LLP as independent auditor; approve amendment to 2024 Incentive Plan to add 600,000 shares; approve amendment to 2024 ESPP to add 150,000 shares; and transact any other business properly before the meeting.
Elect two Class II directors (Stephen A. Nolan and Audrey P. Dunning) to three-year terms expiring in 2029.
Non-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed for fiscal 2025.
This non-binding advisory proposal asks stockholders to approve the 2025 compensation paid to the Company’s named executive officers as disclosed in the proxy statement. Management frames the program as designed to attract, motivate, and retain qualified executives by aligning their interests with stockholders through a mix of base salary, cash bonuses, and significant long-term equity awards (RSUs, PSUs, DSUs) tied to multi-year performance metrics. The company discloses pay-versus-performance data showing fluctuations in compensation actually paid over 2023–2025 tied to stock price movements and performance metric achievement, and it notes that some 2025 compensation included retention and promotion-related awards. Although advisory and non-binding, the Board intends to consider the vote’s outcome when setting future pay, and it has recommended a vote “FOR” on the grounds that the program promotes long-term stockholder value and alignment. Investors may use this vote to signal concerns about pay levels, design, or outcomes—particularly given the company’s recent net losses and impairment charges—so a negative outcome could prompt the Compensation Committee to revise incentive structures or disclosures. The proposal’s risk profile centers on equity-heavy compensation and performance metric calibration; the Compensation Committee discloses limits and governance safeguards (e.g., clawback policies, annual bonus plan, Committee oversight) intended to mitigate excessive risk-taking. Given the disclosed severance/change-in-control arrangements and discretionary bonus determinations, shareholders should evaluate whether incentive outcomes are sufficiently linked to sustained shareholder value and appropriately tempered by governance safeguards. In sum, the say-on-pay vote is a governance signal to the Board and Compensation Committee; management recommends support to validate its current compensation philosophy, but shareholders should weigh alignment, dilution from equity awards, and historical performance when voting.
Ratify the Audit Committee’s appointment of Semple, Marchal and Cooper, LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.
Approve an amendment to the 2024 Incentive Plan to increase the number of shares reserved under the plan by 600,000 shares (raising the total reserved to 2,100,000 shares per the amendment).
The proposal requests shareholder approval to increase the 2024 Incentive Plan share reserve by 600,000 shares, which the formal amendment would reflect by raising the plan’s total authorized delivery amount to 2,100,000 shares. Management argues the increase is necessary to preserve the Company’s ability to grant competitive equity awards (RSUs, PSUs, DSUs and options) used for recruiting, retention, and long-term alignment of executives and employees with stockholders, and warns that failing to increase the reserve could force greater reliance on cash incentives. As of December 31, 2025 the proxy discloses 519,618 shares were available under the 2024 Incentive Plan (and 467,639 as of May 21, 2026), so the requested increase would materially expand the pool available for future grants and reduce immediate run-rate scarcity. The company discloses governance safeguards—such as limits on director grant values, Committee administration, restrictions on repricing without stockholder approval, and clawback policies—that partially mitigate concerns about uncontrolled dilution or opportunistic repricing. Key investor considerations include the dilution and potential overhang resulting from adding 600,000 shares, the projected burn-rate implied by past grants (noting large RSU/PSU grants to executives in 2025), and whether the Committee will use the additional shares primarily for long-term performance-based awards versus time-based grants. The amendment also contains customary adjustment provisions for corporate events and change-in-control acceleration mechanics; investors should evaluate how these mechanics interact with the Company’s M&A strategy and potential successor treatment. If approved, the increase would enable more equity-based compensation without immediate cash expense but could depress near-term EPS and per-share metrics; conversely, it may reduce cash compensation needs and better align management incentives with shareholder return over time. The Board’s unanimous recommendation and the Plan’s stated limits provide some governance protection, but shareholders should weigh the incremental dilution against the operational need for talent retention and the Company’s recent financial performance when deciding how to vote.
Approve an amendment to the 2024 ESPP to increase the number of shares authorized for issuance by 150,000 shares (increasing the ESPP authorization from 250,000 to 400,000 shares).
This proposal asks shareholders to increase the ESPP share reserve by 150,000 shares, taking the plan total from 250,000 to 400,000 shares, to permit additional employee purchases at the plan’s terms. The ESPP offers six-month offerings with a purchase price equal to the lower of 85% of the fair market value on the offering date or the exercise date, subject to per-employee limits ($25,000 fair-market-value-per-calendar-year cap and a maximum of 10,000 shares per offering), and is intended to broaden employee ownership among the Company’s ~191 employees. Management frames the amendment as a tool to enhance retention, morale, and alignment by allowing more employees to participate in an affordable, discounted stock purchase program; the Board unanimously recommends a “FOR” vote. Investor considerations include dilution from increasing the ESPP reserve and the 85% discount, but the program’s per-employee annual and per-offering caps limit concentration and potential excessive issuance to insiders. The company discloses that as of May 21, 2026 there were 92,689 shares available under the ESPP, so the requested increase would materially expand availability for future offerings. From a governance perspective, the ESPP is administered by the Committee with Section 423 qualification objectives, contains adjustment mechanics for corporate events, and permits employer discretion subject to statutory limits, which together provide structure and some investor protections. Overall, the amendment is presented as a relatively modest increase in potential dilution in exchange for broader employee ownership and retention benefits; shareholders should weigh the marginal dilution and discount against the participation limits and the strategic benefit of employee equity participation when voting.
To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | WYNNEFIELD CAPITAL INC | 13.0% | 2,734,349 | $3M |
| 2 | Veradace Capital Management LLC | 6.0% | 1,256,082 | $1M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 688,631 | $819K |
| 4 | LPL Financial LLC | 1.6% | 343,280 | $409K |
| 5 | KENNEDY CAPITAL MANAGEMENT LLC | 1.6% | 326,225 | $388K |
| 6 | Mink Brook Asset Management LLC | 1.4% | 295,587 | $352K |
| 7 | TRUIST FINANCIAL CORP | 1.3% | 276,222 | $329K |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0.8% | 166,163 | $198K |
| 9 | Skylands Capital, LLC | 0.8% | 165,150 | $197K |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 0.6% | 128,792 | $153K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.